| Jessica Quinlan Ratledge, MD | |
|
501 S Burma Ave, Gillette, WY 82716-3426 | |
| (307) 688-1000 | |
| Not Available |
| Full Name | Jessica Quinlan Ratledge |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 14 Years |
| Location | 501 S Burma Ave, Gillette, Wyoming |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912224452 | NPI | - | NPPES |
| 012284800 | Medicaid | FL |
| Facility Name | Location | Facility Type |
|---|---|---|
| Campbell County Health | Gillette, WY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Campbell County Hospital District | 2860392529 | 110 |
News Archive
LinkMed's portfolio company Likvor has been granted CE marking for its instrument for better and safer identification and diagnosis of Normal Pressure Hydrocephalus (NPH).
Platelet-rich plasma derived from blood contains growth factors and other bioactive molecules that promote healing at sites of tissue injury. However, it is difficult to deliver and retain these molecules at a target site, and clinical results have proven to be mixed - until now.
Techulon™ Inc., an early stage life sciences company based in the Virginia Tech Corporate Research Center, has signed an exclusive license with Virginia Tech Intellectual Properties Inc. to market a new theranostic transfection reagent. This new traceable reagent complements Techulon's currently marketed Glyocofect™ transfection platform and expands the company's offering in an $800 million market that is steadily growing at 15% annually.
IBM and University of Antioquia's Tropical Disease Study and Control Program (PECET) today announced a joint research project, Drug Search for Leishmaniasis, using computer power from IBM's World Community Grid.
› Verified 6 days ago
| Entity Name | Campbell County Hospital District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710098868 PECOS PAC ID: 2860392529 Enrollment ID: O20040206000510 |
News Archive
LinkMed's portfolio company Likvor has been granted CE marking for its instrument for better and safer identification and diagnosis of Normal Pressure Hydrocephalus (NPH).
Platelet-rich plasma derived from blood contains growth factors and other bioactive molecules that promote healing at sites of tissue injury. However, it is difficult to deliver and retain these molecules at a target site, and clinical results have proven to be mixed - until now.
Techulon™ Inc., an early stage life sciences company based in the Virginia Tech Corporate Research Center, has signed an exclusive license with Virginia Tech Intellectual Properties Inc. to market a new theranostic transfection reagent. This new traceable reagent complements Techulon's currently marketed Glyocofect™ transfection platform and expands the company's offering in an $800 million market that is steadily growing at 15% annually.
IBM and University of Antioquia's Tropical Disease Study and Control Program (PECET) today announced a joint research project, Drug Search for Leishmaniasis, using computer power from IBM's World Community Grid.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Quinlan Ratledge, MD 501 S Burma Ave, Gillette, WY 82716-3426 Ph: (307) 688-1000 | Jessica Quinlan Ratledge, MD 501 S Burma Ave, Gillette, WY 82716-3426 Ph: (307) 688-1000 |
News Archive
LinkMed's portfolio company Likvor has been granted CE marking for its instrument for better and safer identification and diagnosis of Normal Pressure Hydrocephalus (NPH).
Platelet-rich plasma derived from blood contains growth factors and other bioactive molecules that promote healing at sites of tissue injury. However, it is difficult to deliver and retain these molecules at a target site, and clinical results have proven to be mixed - until now.
Techulon™ Inc., an early stage life sciences company based in the Virginia Tech Corporate Research Center, has signed an exclusive license with Virginia Tech Intellectual Properties Inc. to market a new theranostic transfection reagent. This new traceable reagent complements Techulon's currently marketed Glyocofect™ transfection platform and expands the company's offering in an $800 million market that is steadily growing at 15% annually.
IBM and University of Antioquia's Tropical Disease Study and Control Program (PECET) today announced a joint research project, Drug Search for Leishmaniasis, using computer power from IBM's World Community Grid.
› Verified 6 days ago
Dr. Lowell R Amiotte Ii, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3100 W Lakeway Suite 3, Northern Plains Anesthesia Associates, Gillette, WY 82718 Phone: 307-682-7819 | |
Dr. William J. Forman, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 501 S Burma Ave, Gillette, WY 82716 Phone: 307-688-1524 Fax: 307-687-7243 | |
Nita R. Engineer, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 501 S Burma Ave, Gillette, WY 82716 Phone: 307-688-1824 Fax: 732-271-3543 | |
Dr. Mark Lloyd Wisniewski, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1307 W 3rd St, #b, Gillette, WY 82716 Phone: 801-707-1874 | |
Dr. Erik P. Johnsrud, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 501 S Burma Ave, Gillette, WY 82716 Phone: 307-688-1524 Fax: 307-687-7243 | |
Dr. John L. Mansell, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3100 W Lakeway Rd, Suite 3, Gillette, WY 82718 Phone: 307-696-2996 Fax: 307-670-8250 |